ORBIMED ADVISORS LLC - 31 Dec 2024 SCHEDULE 13G Report for RAPT Therapeutics, Inc. Common Stock, par value $0.0001 per share (RAPT)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED ADVISORS LLC
Security: RAPT Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: RAPT
Shares outstanding: 132,679,394 shares
Disclosed Ownership: 13,135,260 shares
Ownership: 9.9%
Form type: SCHEDULE 13G
Filing time: 14 Feb 2025, 16:32:49 UTC
Date of event: 31 Dec 2024
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	9.9%	13,135,260	0	13,135,260	/s/ Carl L. Gordon	Carl L. Gordon/Member